Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence

Medicine and Dentistry

• Accuracy 100%
• Adjuvant Therapy 16%
• Aptitude 16%
• Biochemical Recurrence 50%
• Biological Marker 66%
• Blood 16%
• Enalapril Maleate 66%
• Endoglin 16%
• Enzyme Immunoassay 16%
• Fibrinogen 33%
• Gleason Score 33%
• Interleukin 6 83%
• Lymph Node 16%
• Obstetric Delivery 16%
• Patient 33%
• Plasma 50%
• Plasminogen 16%
• Plasminogen Activator Inhibitor 16%
• Predictor 33%
• Prognostic Factor 16%
• Prostate Cancer 16%
• Prostatectomy 83%
• Receptor 66%
• Seminal Vesicle 16%
• Surgical Margin 16%
• Therapeutic Procedure 16%
• Transforming Growth Factor 33%
• Urokinase 66%
• Vascular Cell Adhesion Molecule 1 33%
• Vasculotropin 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Biochemical Recurrence 50%
• Biological Marker 66%
• Elimination 16%
• Enalapril Maleate 66%
• Endoglin 16%
• Fibrinogen 33%
• Gleason Score 33%
• Interleukin 6 83%
• Plasminogen 16%
• Plasminogen Activator Inhibitor 16%
• Prostate Cancer 16%
• Receptor 66%
• Transforming Growth Factor 33%
• Urokinase 66%
• Vascular Cell Adhesion Molecule 1 33%
• Vasculotropin 16%

Neuroscience

• Adjuvant Therapy 16%
• Eicosanoid Receptor 66%
• Endoglin 16%
• Enzymes 16%
• Fibrinogen 33%
• Immunoassay 16%
• Interleukin 6 83%
• Lymph Node 16%
• Nomogram 16%
• Plasminogen 16%
• Plasminogen Activator Inhibitor 16%
• Prostate 16%
• Seminal Vesicle 16%
• Transforming Growth Factor 33%
• Urokinase 66%
• VCAM-1 33%